Digestive Health Institute By Dr. Muffi Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 0.22 M
as on 16-11-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.05 Cr
as on 16-11-2024
- Revenue -16.02%
(FY 2023)
- Profit -92.69%
(FY 2023)
- Ebitda 19.98%
(FY 2023)
- Net Worth 3.89%
(FY 2023)
- Total Assets -6.07%
(FY 2023)
About Digestive Health Institute By Dr. Muffi
The Corporate was formerly known as Centre For Obesity & Diabetes Surgery Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹7.05 Cr.
Priyanka Lakdawala and Muffazal Lakdawala serve as directors at the Company.
- CIN/LLPIN
U85100MH2010PTC208775
- Company No.
208775
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Digestive Health Institute By Dr. Muffi?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Lakdawala  | Director | 07-Oct-2010 | Current |
| Muffazal Lakdawala | Director | 07-Oct-2010 | Current |
Financial Performance of Digestive Health Institute By Dr. Muffi.
Digestive Health Institute By Dr. Muffi Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.02% decrease. The company also saw a substantial fall in profitability, with a 92.69% decrease in profit. The company's net worth moved up by a moderate rise of 3.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Digestive Health Institute By Dr. Muffi?
In 2023, Digestive Health Institute By Dr. Muffi had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 16 Sep 2020 | ₹8.97 M | Open |
Sidbi Creation Date: 24 Mar 2017 | ₹6.15 Cr | Open |
How Many Employees Work at Digestive Health Institute By Dr. Muffi?
Digestive Health Institute By Dr. Muffi has a workforce of 6 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Digestive Health Institute By Dr. Muffi, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Digestive Health Institute By Dr. Muffi's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
